AKAM vs RNXT · P/E 27, rev $2.17B vs rev $1.5M
Akamai Technologies Inc (AKAM) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported RNXT revenue for 2026-06-30 was $1.5M. Net income was -$6.4M. RNXT currently screens at market cap $47.0M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the AKAM and RNXT stock pages for the full models.
Not investment advice.